Becker's Healthcare January 18, 2024
Glucagon-like peptide-1 receptor agonists such as Ozempic have surged in popularity over the past year. But what does this increased popularity mean for the ASC industry?
Jackie McLaughlin, BSN, RN, manager of surgical services, outpatient infusions and pain clinic at Aspirus Howard Young Medical Center in Woodruff, Wis., connected with Becker’s to discuss how Ozempic will impact the ASC industry.
Note: This response has been lightly edited for length and clarity.
Question: How will Ozempic impact the ASC industry?
Jackie McLaughlin: Ozempic and other GLP-1 medications have become the hot topic in the surgical world. The American Society of Anesthesiologists recommends that patients on the GLP-1s hold the medication for one week prior to anesthesia. If the patients that are...
Today's Sponsors
Today's Sponsor